ReviewCurrent oncology (Toronto, Ont.)2024

Combining Immune Checkpoint Inhibitors with Loco-Regional Treatments in Hepatocellular Carcinoma: Ready for Prime Time?

Juliette Boilève et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.